Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haoran Biopharma is a China-based biotechnology company specializing in the development and manufacturing of reproductive health and endocrine therapeutics. The company focuses on high-purity gonadotropins and recombinant proteins used in assisted reproductive technology (ART) to treat infertility and hormonal imbalances. Haoran Biopharma has established a significant presence in the Chinese market with a portfolio that includes follicle-stimulating hormones and chorionic gonadotropins. By leveraging advanced protein purification and recombinant DNA technologies, the company aims to provide high-quality, affordable alternatives to international brands in the fertility space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haoran Biopharma.